Top Sites>Drug Development & Delivery - The Latest Methods in Drug Development

# BEGIN W3TC ROBOTS
User-agent: *
Disallow: /wp-content/cache/
# END W3TC ROBOTS

# Drug Development and Delivery: Drug Development and Delivery Magazine

> Drug Development \& Delivery is a print and online publisher that presents the latest scientific methods in drug development for professionals\.

Generated by Yoast SEO v27.3, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [E\-Books](https://drug-dev.com/e-books/)
- [Advertise Where AI and Pharma Decision\-Makers  Look First](https://drug-dev.com/ai-for-pharma/)
- [About Us](https://drug-dev.com/about-us/)
- [Media Planner](https://drug-dev.com/media-planner/)
- [Submission Guidelines](https://drug-dev.com/submission-guidelines/)

## Posts
- [SPECIAL FEATURE \- Bioavailability \& Solubility: Experimental Techniques Combined With Computational Decision\-Making Rapidly ID the Most Viable Enhancement Pathway](https://drug-dev.com/special-featur-bioavailability-solubility-experimental-techniques-combined-with-computational-decision-making-rapidly-id-the-most-viable-enhancement-pathway/): Contributor Cindy H\. Dubin highlights other ways formulators are relying on automation, such as Artificial Intelligence and Machine Learning, and how these tools are being combined with experimental confirmation to identify the most promising development strategies\.
- [Alcami to Acquire Contract Packaging Organization Tjoapack](https://drug-dev.com/alcami-to-acquire-contract-packaging-organization-tjoapack/)
- [MilliporeSigma Launches First Bio\-Based Solvent Portfolio for High\-Performance Liquid Chromatography](https://drug-dev.com/milliporesigma-launches-first-bio-based-solvent-portfolio-for-high-performance-liquid-chromatography/)
- [Crown Bioscience \& Turbine Partner to Connect AI\-Driven Prediction With Organoid Validation in Translational Oncology](https://drug-dev.com/crown-bioscience-turbine-partner-to-connect-ai-driven-prediction-with-organoid-validation-in-translational-oncology/)
- [Gerresheimer \& Milliken Partner to Advance Performance \& Protection With LeneX UltraGuard Technology](https://drug-dev.com/gerresheimer-milliken-partner-to-advance-performance-protection-with-lenex-ultraguard-technology/)

## Videos
- [2026 Drug Development Outlook: What Industry Insiders Are Saying](https://drug-dev.com/videos/2026-drug-development-outlook-what-industry-insiders-are-saying/)
- [Better Bioavailability Faster Timelines with Ascendia Pharmaceutical Solutions](https://drug-dev.com/videos/better-bioavailability-faster-timelines-with-ascendia-pharmaceutical-solutions/)

## Webinars
- [ON\-DEMAND WEBINAR: Drug Product Design for Delivery of Challenging Molecules](https://drug-dev.com/webinars/on-demand-webinar-drug-product-design-for-delivery-of-challenging-molecules/): In this talk we illustrate several case studies demonstrating how a fundamental understanding of molecular properties combined with a strategic vision for drug product design can lead to effective and advanceable formulations for even the most challenging drug products\.
- [WEBINAR \- Vytal: The RTU Snap\-Fit System for Container Closure Solutions – Setting the Standard for the Future](https://drug-dev.com/webinars/vytal-the-rtu-snap-fit-system-for-container-closure-solutions-setting-the-standard-for-the-future/): In recent decades, the landscape of parenteral drug production has undergone significant transformation, driven by the emergence of novel molecules and advanced therapies\. The pharmaceutical industry has witnessed a notable shift towards biologics, mAbs, and cell\-based therapies, which now represent some of the most successful pharmaceutical products globally\.
- [WEBINAR ON DEMAND: Precision at Scale: Enabling Novel Therapeutics With Nanoparticle Manufacturing](https://drug-dev.com/webinars/webinar-precision-at-scale-enabling-novel-therapeutics-with-nanoparticle-manufacturing/): Watch this on\-demand webinar to learn about the key steps and considerations in bringing novel nanoparticle\-based therapeutics from early R\&D to commercial stages\. Drawing from our 20 years of experience in the CDMO space, we cover critical topics unique to nanomaterials\.\.\.\.\.
- [WEBINAR: Introducing Key Concepts in Tableting Research: Unleashing Essential Concepts and Strategies for Enhanced Formulation Development](https://drug-dev.com/webinars/webinar-introducing-key-concepts-in-tableting-research-unleashing-essential-concepts-and-strategies-for-enhanced-formulation-development/): Tableting can present a series of challenges, particularly when dealing with formulations that have poor flowability, low compressibility, or high cohesivity\. These issues can lead to manufacturing inefficiencies\.\.\.\.
- [WEBINAR ON DEMAND: Advantages of Carbopol® Polymers in Oral Formulations](https://drug-dev.com/webinars/webinar-on-demand-advantages-of-carbopol-polymers-in-oral-formulations/): In this video, the Lubrizol team together with the IMCD US team takes you through formulation aspects of Carbopol® polymers as well as the results of a case study on an Acetaminophen oral suspension formulation\.

## Whitepapers
- [WHITE PAPER \- Stop Guessing\. Start Predicting: Rethinking Early Oral Drug Development](https://drug-dev.com/whitepapers/white-papaer-stop-guessing-start-predicting-rethinking-early-oral-drug-development/): This article explores how AI\-driven predictive insights reduce uncertainty in early oral drug development, enabling smarter decisions on solubility, dosing, stability, and scale\-up while preserving API, accelerating timelines, and de\-risking clinical success \.
- [WHITE PAPER \- Small Molecules: Choosing the Right Development Path](https://drug-dev.com/whitepapers/white-paper-small-molecules-choosing-the-right-development-path/): This white paper outlines a structured, risk\-minimized approach to early CMC \(Chemistry, Manufacturing, and Controls\) development for small\-molecule drugs—particularly for startups and virtual pharma companies with limited resources\.
- [WHITE PAPER \- How Advanced Containment Technology Is Reshaping High\-Potency API Micronization](https://drug-dev.com/whitepapers/white-paper-how-advanced-containment-technology-is-reshaping-high-potency-api-micronization/): Harry Wade, Technical Associate, and Rosie Bird, EHS Lead, Catalent Dartford, review how for many high\-potency APIs, micronization is not a downstream convenience but a critical performance step\. Particle size distribution directly influences dissolution behavior, bioavailability, blend uniformity, and dose accuracy, particularly when therapeutic doses are measured in micrograms\.
- [WHITE PAPER \- Advancements in Intradermal Delivery: From Historic Techniques to Modern Innovations](https://drug-dev.com/whitepapers/whitepaper-advancements-in-intradermal-delivery-from-historic-techniques-to-modern-innovations/): This white paper explores the evolution of intradermal delivery methods, comparing historic methods of delivery such as the Mantoux technique with modern innovations such as the Terumo Immucise™ Intradermal Injection System\. 
- [WHITE PAPER \- An Insoluble Problem? Overcoming Oral Drug Solubility Challenges With Functional Polymers](https://drug-dev.com/whitepapers/white-paper-an-insoluble-problem-overcoming-oral-drug-solubility-challenges-with-functional-polymers/): There are three key factors that need to be controlled when designing a drug product for solubility enhancement: the polymeric carrier; the manufacturing process; and the match to the desired API\. By controlling these three factors bioavailability, drug release profile and manufacturability of your final drug product can be controlled\.

## Company Profiles
- [Proveris Scientific](https://drug-dev.com/company-profiles/proveris-scientific/)
- [Datwyler](https://drug-dev.com/company-profiles/datwyler/)
- [Upperton Pharma Solutions ](https://drug-dev.com/company-profiles/upperton-pharma-solutions/)
- [Resilience US, LLC](https://drug-dev.com/company-profiles/resilience/)
- [Nipro PharmaPackaging](https://drug-dev.com/company-profiles/nipro-pharmapackaging/)

## Tech Showcase
- [CDMO Services](https://drug-dev.com/tech_showcase/cdmo-services-2/)
- [Contract Development \& Manufacturing](https://drug-dev.com/tech_showcase/contract-development-manufacturing-2/)
- [Pharma Solutions](https://drug-dev.com/tech_showcase/pharma-solutions-2/)
- [Global CRMO](https://drug-dev.com/tech_showcase/global-crmo-2/)
- [CMC Services](https://drug-dev.com/tech_showcase/cmc-services/)

## Video Spotlights
- [Milipore Sigma \- Partek](https://drug-dev.com/video_spotlights/milipore-sigma-partek/)
- [Ajinomoto](https://drug-dev.com/video_spotlights/ajinomoto/)

## Industry Events
- [RDD \(Respiratory Drug Delivery\)](https://drug-dev.com/industry_events/rdd-respiratory-drug-delivery/)
- [INTERPHEX](https://drug-dev.com/industry_events/interphex/)
- [AAPS PharmSci 360](https://drug-dev.com/industry_events/aaps-pharmsci-360/)
- [PODD \(Partnership Opportunities in Drug Delivery\)](https://drug-dev.com/industry_events/podd-partnership-opportunities-in-drug-delivery/)
- [CPhI Milan](https://drug-dev.com/industry_events/cphi-milan/)

## Issues
- [March/April 2026](https://drug-dev.com/issues/march-april-2026/)
- [January/February 2026](https://drug-dev.com/issues/january-february-2026/)
- [November/December 2024](https://drug-dev.com/issues/november-december-2024/)
- [November/December 2025](https://drug-dev.com/issues/november-december-2025/)
- [October 2025](https://drug-dev.com/issues/october-2025/)

## Expert Content
- [America’s Next Healthcare Crisis Is Already Here \- And We’re Not Ready](https://drug-dev.com/expert-content/americas-next-healthcare-crisis-is-already-here-and-were-not-ready/): Bryn L\. Dubin, Master’s Student at the LBJ School of Public Affairs studying health and economic policy\. Dubin has federal and state legislative and policy analysis experience\.
- [Executive Interview: Advancing Regenerative Medicine for Chronic Disease](https://drug-dev.com/expert-content/executive-interview-advancing-regenerative-medicine-for-chronic-disease/): Lance Alstodt, CEO of BioRestorative Therapies, discusses the development of its lead cell therapy candidate BRTX\-100, the evolving regulatory and manufacturing landscape for autologous therapies, and how regenerative platforms could reshape treatment paradigms for chronic conditions\.
- [eBook: Understanding the Foundation of LNP Formulation Success](https://drug-dev.com/expert-content/ebook-understanding-the-foundation-of-lnp-formulation-success/): Lipid nanoparticles \(LNPs\) are one of the most significant advances in drug delivery in decades\. But developing successful LNP formulations demands deep knowledge of their key building blocks: Lipids\.
- [The Most Underutilized Route in Drug Delivery: How Vaginal Therapeutics Are Finally Getting the Platform They Deserve](https://drug-dev.com/expert-content/the-most-underutilized-route-in-drug-delivery-how-vaginal-therapeutics-are-finally-getting-the-platform-they-deserve/): Before we dig into improved delivery methods, we need to acknowledge a more basic issue: women need more therapeutics in the first place\. Persistent gaps exist across conditions that uniquely or disproportionally affect women\. Gynecologic infections, endometriosis, the vaginal microbiome\. Menopause, contraception, oncology\.
- [Biocatalysis Without Barriers for Efficient Small Molecule Process Development](https://drug-dev.com/expert-content/biocatalysis-without-barriers-for-efficient-small-molecule-process-development/): As the biocatalytic toolbox expands, chemists have gained access to a wider range of catalytic options, enabling improved stereo\- and regioselectivity, simplified chemical synthesis routes, improved process mass intensity \(PMI\), reduced environmental impact and stronger process economics\.

## Categories
- [Market News \& Trends](https://drug-dev.com/category/market-news-and-trends/)
- [Formulation Development](https://drug-dev.com/category/formulation-development/)
- [Bio Platforms](https://drug-dev.com/category/bio-platforms/)
- [Exclusive Online Content](https://drug-dev.com/category/exclusive-online-content/)
- [Contract Services](https://drug-dev.com/category/contract-services/)

## Optional
- [Sitemap index](https://drug-dev.com/sitemap_index.xml)